XTX Topco Ltd Reduces Stock Position in Integer Holdings Co. (NYSE:ITGR)

XTX Topco Ltd lessened its holdings in Integer Holdings Co. (NYSE:ITGR - Free Report) by 66.9% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,239 shares of the medical equipment provider's stock after selling 4,525 shares during the period. XTX Topco Ltd's holdings in Integer were worth $297,000 at the end of the most recent reporting period.

Several other institutional investors also recently modified their holdings of the business. Summit Investment Advisors Inc. increased its holdings in Integer by 5.3% during the fourth quarter. Summit Investment Advisors Inc. now owns 3,488 shares of the medical equipment provider's stock worth $462,000 after buying an additional 175 shares during the last quarter. Townsquare Capital LLC grew its position in shares of Integer by 16.3% during the 4th quarter. Townsquare Capital LLC now owns 31,467 shares of the medical equipment provider's stock valued at $4,170,000 after acquiring an additional 4,412 shares during the period. Sterling Capital Management LLC increased its stake in shares of Integer by 472.9% during the 4th quarter. Sterling Capital Management LLC now owns 338 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 279 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Integer in the 4th quarter worth approximately $38,073,000. Finally, Riverwater Partners LLC purchased a new position in Integer in the fourth quarter valued at approximately $1,588,000. 99.29% of the stock is owned by institutional investors.

Integer Trading Down 0.5 %

Integer stock traded down $0.58 during mid-day trading on Monday, hitting $122.83. The company's stock had a trading volume of 534,414 shares, compared to its average volume of 346,168. The business has a 50 day moving average price of $119.58 and a 200-day moving average price of $130.28. Integer Holdings Co. has a 12 month low of $104.93 and a 12 month high of $146.36. The stock has a market cap of $4.29 billion, a price-to-earnings ratio of 36.56, a price-to-earnings-growth ratio of 1.72 and a beta of 1.09. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.95 and a quick ratio of 2.09.

Integer (NYSE:ITGR - Get Free Report) last issued its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 earnings per share for the quarter, beating the consensus estimate of $1.27 by $0.04. Integer had a return on equity of 11.65% and a net margin of 6.92%. The company had revenue of $437.39 million during the quarter, compared to analysts' expectations of $428.51 million. Integer's quarterly revenue was up 7.3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.14 EPS. As a group, analysts forecast that Integer Holdings Co. will post 6.01 EPS for the current year.

Wall Street Analysts Forecast Growth

ITGR has been the topic of several research reports. KeyCorp lowered their target price on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a research note on Monday, April 21st. Truist Financial set a $150.00 price objective on Integer and gave the company a "buy" rating in a research note on Friday. Benchmark cut their target price on shares of Integer from $150.00 to $140.00 and set a "buy" rating for the company in a research report on Friday. Oppenheimer lowered shares of Integer from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. Finally, StockNews.com downgraded shares of Integer from a "hold" rating to a "sell" rating in a report on Friday. One investment analyst has rated the stock with a sell rating, two have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Integer currently has a consensus rating of "Moderate Buy" and a consensus price target of $145.56.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.